GC Biopharma Corp.
Records under this name other than the patents GC Biopharma Corp. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 3 patents it holds.
Showing 1 to 8 of 8 · Back to GC Biopharma Corp.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 11,203,749 | Factor VII Polypeptides That Are Modified and Uses Thereof Formerly held In force · High confidence | In force | High confidence | |
| US 10,160,961 | Factor VII Polypeptides That Are Modified and Uses Thereof Formerly held In force · High confidence | In force | High confidence | |
| US 9,476,037 | Factor VII polypeptides that are modified and uses thereof Formerly held In force · High confidence | In force | High confidence | |
| US 8,519,103 | Factor VII Polypeptides That Are Modified and Uses Thereof Formerly held In force · High confidence | In force | High confidence | |
| US 11,266,724 | Modified Factor VII Polypeptides for Subcutaneous Administration and On-Demand Treatment Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 8,778,870 | Modified Factor IX Polypeptides and Uses Thereof Lapsed on the fee record Ended Jul 15, 2026 · High confidence | Lapsed on the fee record | Ended Jul 15, 2026 | High confidence |
| US 10,982,203 | Modified Factor IX Polypeptides and Uses Thereof Lapsed on the fee record Ended Apr 20, 2025 · High confidence | Lapsed on the fee record | Ended Apr 20, 2025 | High confidence |
| US 8,383,388 | Modified Coagulation Factor IX Polypeptides and Use Thereof for Treatment Lapsed on the fee record Ended Feb 26, 2025 · High confidence | Lapsed on the fee record | Ended Feb 26, 2025 | High confidence |